Literature DB >> 24816469

Unusual effects of GH deficiency in adults: a review about the effects of GH on skin, sleep, and coagulation.

F Tanriverdi1, Z Karaca, K Unluhizarci, F Kelestimur.   

Abstract

Based on the literature data in the last two decades, growth hormone deficiency (GHD) in adults has been accepted as a clinical entity. Due to the presence of GH and IGF-I receptors throughout the body, the physiological effects of the GH-IGF-I axis are still under investigation. The effects of GH on skin, sleep, and coagulation parameters in adults have only been investigated in detail only in the recent years. In this review, our aim was to summarize the literature regarding the effects of GHD and GH replacement treatment on the skin, sleep, and coagulation parameters in adults.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24816469     DOI： 10.1007/s12020-014-0276-0

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


  101 in total

1.  Ageing of the skin during menopause.

Authors:  G Broniarczyk-Dyla; E Joss-Wichman
Journal:  J Eur Acad Dermatol Venereol       Date:  2001-09       Impact factor: 6.166

Review 2.  Epidermal homeostasis: the role of the growth hormone and insulin-like growth factor systems.

Authors:  Stephanie R Edmondson; Susan P Thumiger; George A Werther; Christopher J Wraight
Journal:  Endocr Rev       Date:  2003-12       Impact factor: 19.871

3.  Localization of the growth hormone receptor/binding protein in skin.

Authors:  P E Lobie; W Breipohl; D T Lincoln; J García-Aragón; M J Waters
Journal:  J Endocrinol       Date:  1990-09       Impact factor: 4.286

4.  Sleep, awakenings, and insulin-like growth factor-I modulate the growth hormone (GH) secretory response to GH-releasing hormone.

Authors:  E Van Cauter; A Caufriez; M Kerkhofs; A Van Onderbergen; M O Thorner; G Copinschi
Journal:  J Clin Endocrinol Metab       Date:  1992-06       Impact factor: 5.958

5.  Growth hormone deficiency and cardiovascular risk: do we need additional markers?

Authors:  M Gola; A Giustina
Journal:  Endocrine       Date:  2012-10       Impact factor: 3.633

6.  Skin morphological changes in growth hormone deficiency and acromegaly.

Authors:  M Lange; J Thulesen; U Feldt-Rasmussen; N E Skakkebaek; N Vahl; J O Jørgensen; J S Christiansen; S S Poulsen; S B Sneppen; A Juul
Journal:  Eur J Endocrinol       Date:  2001-08       Impact factor: 6.664

7.  Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency.

Authors:  T A Elhadd; T A Abdu; J Oxtoby; G Kennedy; M McLaren; R Neary; J J Belch; R N Clayton
Journal:  J Clin Endocrinol Metab       Date:  2001-09       Impact factor: 5.958

8.  Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly.

Authors:  A Sartorio; M Cattaneo; P Bucciarelli; B Bottasso; S Porretti; P Epaminonda; G Faglia; M Arosio
Journal:  Exp Clin Endocrinol Diabetes       Date:  2000       Impact factor: 2.949

9.  Polysomnographic findings in five adult patients with pituitary insufficiency before and after cessation of human growth hormone replacement therapy.

Authors:  Wilhelm Nolte; Carsten Rädisch; Andrea Rodenbeck; Jens Wiltfang; Michael Hüfner
Journal:  Clin Endocrinol (Oxf)       Date:  2002-06       Impact factor: 3.478

10.  Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.

Authors:  A Hamsten; U de Faire; G Walldius; G Dahlén; A Szamosi; C Landou; M Blombäck; B Wiman
Journal:  Lancet       Date:  1987-07-04       Impact factor: 79.321
View more
  5 in total

1.  Can a glucagon stimulation test characterized by lower GH cut-off value be used for the diagnosis of growth hormone deficiency in adults?

Authors:  Halit Diri; Zuleyha Karaca; Yasin Simsek; Fatih Tanriverdi; Kursad Unluhizarci; Ahmet Selcuklu; Fahrettin Kelestimur
Journal:  Pituitary       Date:  2015-12       Impact factor: 4.107

Review 2.  Growth Hormone Deficiency and Excessive Sleepiness: A Case Report and Review of the Literature.

Authors:  Anisha Gohil; Erica Eugster
Journal:  Pediatr Endocrinol Rev       Date:  2019-09

3.  Molecular skin changes in Cushing syndrome and the effects of treatment.

Authors:  Z Karaca; S Taheri; S T Firat; M Borlu; G Zararsiz; E Mehmetbeyoglu; A Sezgin Caglar; A Hacioglu; F Tanriverdi; K Unluhizarci; F Kelestimur
Journal:  J Endocrinol Invest       Date:  2020-05-14       Impact factor: 4.256

Review 4.  Targeting growth hormone function: strategies and therapeutic applications.

Authors:  Man Lu; Jack U Flanagan; Ries J Langley; Michael P Hay; Jo K Perry
Journal:  Signal Transduct Target Ther       Date:  2019-02-08

5.  Effects of Composite Supplement Containing Collagen Peptide and Ornithine on Skin Conditions and Plasma IGF-1 Levels-A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Naoki Ito; Shinobu Seki; Fumitaka Ueda
Journal:  Mar Drugs       Date:  2018-12-03       Impact factor: 5.118
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.